Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-16-003898
Filing Date
2016-03-08
Accepted
2016-03-08 17:10:09
Documents
71
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rigl-20151231x10k.htm 10-K 2431606
2 EX-23.1 rigl-20151231ex2316e7124.htm EX-23.1 13492
3 EX-31.1 rigl-20151231ex311e2529d.htm EX-31.1 15663
4 EX-31.2 rigl-20151231ex3124522cd.htm EX-31.2 13511
5 EX-32.1 rigl-20151231ex3217bb256.htm EX-32.1 10717
6 GRAPHIC rigl20151231x10k001.jpg GRAPHIC 19291
  Complete submission text file 0001558370-16-003898.txt   8996203

Data Files

Seq Description Document Type Size
7 EX-101.INS rigl-20151231.xml EX-101.INS 2083176
8 EX-101.SCH rigl-20151231.xsd EX-101.SCH 54172
9 EX-101.CAL rigl-20151231_cal.xml EX-101.CAL 49682
10 EX-101.DEF rigl-20151231_def.xml EX-101.DEF 195681
11 EX-101.LAB rigl-20151231_lab.xml EX-101.LAB 546304
12 EX-101.PRE rigl-20151231_pre.xml EX-101.PRE 377525
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29889 | Film No.: 161492322
SIC: 2834 Pharmaceutical Preparations